Heartflow (HTFL) Return on Capital Employed (2025 - 2026)

Heartflow (HTFL) posted quarterly Return on Capital Employed of 19.6% for Q4 2025, up 26.59% quarter-over-quarter from 26.69% in Q3 2025.

Heartflow (HTFL) Return on Capital Employed (2025 - 2026) Analysis & Trends

Heartflow's Return on Capital Employed history runs 1 years deep, the most recent figure standing at 19.6% for Q4 2025.

In Q4 2025, Return on Capital Employed changed N/A year-over-year to 19.6%; the TTM figure through Dec 2025 stood at 19.6% (changed N/A YoY), while the FY2025 annual figure was 32.57%, changed N/A from the prior year.
Return on Capital Employed for Q4 2025 stood at 19.6%, up from 26.69% in the prior quarter.
The five-year high for Return on Capital Employed was 19.6% in Q4 2025, with the low at 55.5% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROCE (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	13.00%
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	9.85%
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	10.67%
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	-9.77%
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	31.58%
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	-8.46%
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	4.91%
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	20.35%
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	-20.94%
10	Privia Health	2.78 Bn	2.42 Bn	-	5.48%

Download Data